Aspergillosis is an infection triggered by a collective of molds called Aspergillus. These molds are commonly found in the environment and are typically harmless to healthy individuals. However, in people with weakened immune systems or underlying lung conditions, such as asthma or cystic fibrosis, Aspergillus can cause serious respiratory problems. The infection usually occurs when spores of the mold are inhaled into the lungs, where they can colonize and cause inflammation. Symptoms of aspergillosis can vary depending on the type and severity of the infection but may include coughing, wheezing, chest pain, and shortness of breath. Treatment typically involves antifungal medications to control the infection and may also include measures to address underlying health conditions and boost the immune system.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea
Stephanie Maltais, University of Montreal, Canada
Title : The role of social sciences in operationalizing the One Health approach: A case study of the DOPERAUS project in Guinea and the Democratic Republic of Congo
Stephanie Maltais, University of Montreal, Canada